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Background: A strong consensus exists for a systematic approach to linguistic validation of patient reported
outcome measures (PROMs) and discrete methods for assessing their psychometric properties. Despite the need for
robust evidence of the appropriateness of measures, transition from linguistic to psychometric validation is poorly
documented or evidenced. This paper demonstrates the importance of linking linguistic and psychometric testing
through a purposeful stage which bridges the gap between translation and large-scale validation.
Findings: Evidence is drawn from a study to develop a Welsh language version of the Beck Depression Inventory-II
(BDI-II) and investigate its psychometric properties. The BDI-II was translated into Welsh then administered to
Welsh-speaking university students (n = 115) and patients with depression (n = 37) concurrent with the English BDI-
II, and alongside other established depression and quality of life measures. A Welsh version of the BDI-II was
produced that, on administration, showed conceptual equivalence with the original measure; high internal
consistency reliability (Cronbach’s alpha = 0.90; 0.96); item homogeneity; adequate correlation with the English BDI-II
(r = 0.96; 0.94) and additional measures; and a two-factor structure with one overriding dimension. Nevertheless, in
the student sample, the Welsh version showed a significantly lower overall mean than the English (p= 0.002); and
significant differences in six mean item scores. This prompted a review and refinement of the translated measure.
Conclusions: Exploring potential sources of bias in translated measures represents a critical step in the
translation-validation process, which until now has been largely underutilised. This paper offers important
findings that inform advanced methods of cross-cultural validation of PROMs.
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languageBackground
Patient reported outcome measures (PROMs) are used
increasingly in clinical practice and research where they
must be fit for purpose and sensitive to patients’ cultural
and linguistic needs [1]. Thus PROMs are required in a
range of different languages; and the need to maintain
reliability and validity of measures is paramount [2].
Whilst a rigorous multi-step approach to translation is
endorsed [3,4], there are no clear recommendations* Correspondence: gwerfyl.w.roberts@bangor.ac.uk
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reproduction in any medium, provided the orabout the early assessment of reliability and validity of
translated measures before large-scale testing. We
demonstrate the value of undertaking early checks to re-
fine measures. Our case in point is the translation and
validation of the Beck Depression Inventory II (BDI-II)
[5] for the Welsh language. The measure is widely used
both clinically and in research for measuring the severity
of depression and response to psychological and medical
interventions; and it is one of the PROMS recommended
by the Welsh and UK Governments for screening de-
pression in high risk populations in primary care.
The BDI has been translated into numerous languages
and is psychometrically robust for use in countriesl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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language version currently available. Here, we report the
linguistic and psychometric validation of the Welsh
BDI-II and highlight the value of embedding early stage
validation within the instrument development phase.
Methods
Linguistic validation
Under licence of the publisher and adopting the Inter-
national Society for Pharmacoeconomics and Outcomes
Research (ISPOR) guidelines [3], two independent trans-
lators produced a Welsh BDI-II. Reconciliation of these
translations into a merged document was undertaken
through consensus. This version was then translated
back into English by a third independent translator for
quality assurance. Comparison between the back transla-
tion and original measure highlighted any discrepancies
which were revised through discussion and consensus.
Eight Welsh-speaking lay respondents (Table 1) were





N 8 115 37
Gender, n (%)
Female 5 (62.5) 94 (81.7) 22 (59.5)
Male 3 (37.5) 21 (18.3) 15 (40.5)
Age, n (%)
<17 years 1 (12.5)
17-24 years 2 (25) 73 (63.5) 1 (2.7)
25-34 years 2 (25) 18 (15.7) 7 (18.9)
35-44 years 1 (12.5) 16 (13.9) 13 (35.1)
45-54 years 2 (25) 7 (6.1) 7 (18.9)
> 54 years 0 (0) 1 (0.9) 9 (24.3)
Percentage of time Welsh is spoken
Range N/A 5-100 5-100
Median (IQR) N/A 90 (60 to 95) 70 (80 to 95)
Missing 5 6
BDI-II: Welsh
Range N/A 0-35 19-62
Mean (SD) N/A 5.1 (5.9) 38.4 (11.9)
Median (IQR) N/A 3 (1 to 7) 39 (28.5-46)
Missing 4 -
BDI-II: English
Range N/A 0-34 15-61
Mean (SD) N/A 5.7 (5.5) 37.7 (11.5)
Median (IQR) N/A 5 (1.1 to 8) 38 (28.5-47)
Missing 1 -comprehension and interpretation of the draft measure.
Remaining discrepancies were identified by comparing
these interpretations with the original measure. A final
Welsh translation was agreed and subjected to an early
exploratory stage of psychometric testing. In line with
previous validation of the BDI-II [5], two test groups
were identified: (i) a student sample, and (ii) a clinical
sample of patients with depression (Table 1).
Psychometric testing
In keeping with theoretical propositions [1], the Welsh
BDI-II was expected to have (a) a two-factor structure
similar to the original model presented, and (b) adequate
correlations with other accepted depression scales, and
negative correlations with quality of life scales. These hy-
potheses were tested by (a) performing a confirmatory
factor analysis on the student sample data and (b)
examining Pearson correlation coefficients between the
Welsh BDI-II and other pre-specified measures, includ-
ing the English BDI-II, for both the clinical and student
samples. Further exploratory item level analysis was
undertaken to identify potential sources of bias.
Student sample
Out of 144 bilingual (Welsh/English) university students
approached, 115 (80%) consented to participate in the
study. Data collection was undertaken during 2009 in a
classroom setting, outside teaching hours, where partici-
pants were asked to complete the following measures in
the order listed:
(a)BDI-II (English) [5]
(b)European Quality of Life-5 Dimensions (EQ-5D)
(Welsh) [9]
(c)Hospital Anxiety and Depression Scale (HADS)
(English) [10]




A sample of Welsh-speaking patients with depression
was recruited to participate in this validation study be-
tween 2009 and 2010 through the Folate Augmentation
of Treatment - Evaluation for Depression (FolATED)
trial [12]. Thirty-seven of 81 (46%) bilingual speakers
consented to participate. Consistent with the trial proto-
col, the following English measures were completed at
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For the validation study, participants were also invited
to complete the Welsh BDI-II.
Bangor University School of Healthcare Sciences Ethics
Committee approved the student study whilst the Multi-
centre Research Ethics Committee for Wales approved
the patient study through the FolATED trial processes
[12]. All data were anonymised and analysed using PASW
[14] and AMOS [15] for Windows (version 18.0). All
statistical tests were two-sided, and P-values of ≤0.05 were
considered statistically significant.
Results
The Welsh BDI-II showed a high level of internal
consistency for both student (α= 0.90) and clinical
(α= 0.96) samples similar to that reported for the English
BDI-II (α= 0.87 student sample; α= 0.92 clinical sample)
and by Beck and colleagues (α= 0.93) [5]. The Welsh
measure demonstrated a high degree of concurrent and
discriminant validity with a positive correlation with
HADS (student sample: depression component r = 0.71;
anxiety component r = 0.66); and negative correlation
with the mental component of SF-12v2 (student sample:
r =−0.74; clinical sample: r =−0.71) and EQ-5D (student
sample: r =−0.66; clinical sample: r =−0.55). Factor ana-
lysis revealed a two factor structure emerging from both
samples for each language version; with one overridingFigure 1 Bland Altman plot for Welsh and English BDI-II (student samdepression-related dimension. However, confirmatory
factor analysis of the student data revealed that the three
indices did not meet the criteria for good fit (GFI = 0.54,
AGFI = 0.47, RMR= 0.06).
The student Welsh BDI-II depression score was highly
correlated to the English (r = 0.94), but the overall mean
was significantly lower (Welsh M=5.09, SD=5.85; English
M=5.70, SD= 5.5), t110 = 3.217, p=0.002. The Bland
Altman graph [16] (Figure 1) revealed a small but signifi-
cant bias towards the English BDI-II, showing a slightly
higher score than its Welsh comparator; the mean
difference (MD) in scores being just over half a point
(MD=0.61, 95% limits of agreement 0.23 to 1.00). The de-
pression score on the Welsh BDI-II was also highly corre-
lated to the English (r = 0.96) within the clinical sample
but no statistically significant differences were noted be-
tween the mean scores.
Given the evidence of a seemingly biased measure and
poorly fitting confirmatory factor analysis for the student
sample, further item-level exploration was performed.
No differences were found within the clinical sample be-
tween mean scores of the Welsh and English BDI-II for
the individual items; and there were no indications of
asymmetry. However, within the student sample, six
items showed statistical significant differences on a
paired t-test comparing mean scores between the Welsh
and English BDI-II. Three of these items also indicated
significant asymmetry (Table 2). Close inspection of theple).
Table 2 Item level analysis of the BDI-II (student sample)










Welsh English Welsh English Welsh English Welsh English p-value
1. Sadness 0.05 0.04 0.21 0.21 4.5 4.39 0.48 0.33 0.79 1
2. Pessimism 0.26 0.28 0.46 0.47 27.52 27.19 0.52 0.43 0.76 0.99
3. Past Failure 0.19 0.17 0.48 0.44 14.55 14.04 0.55 0.37 0.76 0.77
4. Loss of Pleasure 0.18 0.18 0.39 0.41 17.27 16.67 0.6 0.36 0.66 0.8
5. Guilty Feelings 0.27 0.32 0.58 0.54 22.02 28.95 0.71 0.57 0.73 0.26
6. Punishment Feelings* 0.02 0.06 0.14 0.24 1.8 6.14 0.36 0.31 0.43 0.03
7. Self-Dislike* 0.25 0.37 0.59 0.63 20 28.95 0.59 0.55 0.61 0.3
8. Self - Criticalness* 0.35 0.47 0.62 0.72 29.09 34.21 0.7 0.67 0.74 0.75
9. Suicidal Thoughts* 0.03 0.07 0.17 0.26 2.7 7.02 0.38 0.14 0.53 0.03
10. Crying 0.22 0.18 0.54 0.45 18.18 14.91 0.55 0.43 0.82 0.54
11. Agitation 0.21 0.29 0.41 0.46 20.9 28.95 0.6 0.52 0.63 0.07
12. Loss of interest 0.08 0.12 0.28 0.32 8.2 12.28 0.45 0.25 0.6 0.16
13. Indecisiveness 0.33 0.34 0.63 0.67 26.36 25.44 0.62 0.57 0.69 0.63
14. Worthlessness 0.2 0.21 0.51 0.56 14.55 14.91 0.61 0.56 0.66 0.99
15. Loss of Energy* 0.36 0.46 0.48 0.5 35.5 45.61 0.42 0.37 0.66 0.02
16. Changes in Sleeping Pattern 0.51 0.55 0.69 0.68 41.8 46.4 0.5 0.5 0.94 0.68
17. Irritability 0.23 0.28 0.42 0.49 22.7 25.44 0.59 0.51 0.63 0.73
18. Changes in Appetite 0.29 0.34 0.55 0.56 24.8 29.8 0.39 0.39 0.9 0.94
19. Concentration Difficulty 0.37 0.38 0.57 0.56 31.82 33.33 0.61 0.62 0.58 0.56
20. Tiredness or Fatigue* 0.44 0.54 0.55 0.58 41.82 50 0.57 0.56 0.72 0.6
21. Loss of interest in Sex 0.23 0.21 0.5 0.49 19.09 18.42 0.28 0.25 0.97 0.99
N=106 for Welsh BDI-II and 112 for English BDI-II, * = Difference in mean is significant at the .05 level (paired t-test).
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pretations that may have led to an underscoring of the
item in the Welsh BDI-II (Table 3).
Discussion
We have demonstrated how a thorough and rigorous ap-
proach to early validation can inform the refinement of
translated outcome measures. Here, we examine the
juxtaposition of these two processes (often reported in-
dependently in the literature); and discuss the wider
implications for a revision of the guidelines and methods
of cross-cultural validation of PROMs.
Our results support previous findings on the psycho-
metric properties of the BDI-II, particularly in relation
to the two-factor structure [5,7,8,17]; and concurrent
validity with other depression and quality of life mea-
sures [18-20]. This indicates that the translation and
early validation process was relatively successful. Despite
the high correlation between the two language versions,
the observed poor fit (indicating poor construct validity)
and bias led us to explore potential sources of bias and
items of concern. This prompted further scrutiny of thetranslated items to rule out any inaccuracies or misinter-
pretations, thus providing the opportunity to amend any
problematic items. Whilst this step is acknowledged in
the literature [4,21], it attracts little attention within
current translation and validation guidelines [3,22].
In light of our evidence, it is possible that ambiguities in
translation at the lower end of the scale biased response to
some items. This interpretation is strengthened as we
detected no other subtle dissonances when the remaining
items were similarly scrutinised. Moreover, since the
student data aggregated to the lower end of the scale, this
bias is not observed amongst the clinical sample because
the majority reported symptoms of moderate to severe
depression. Thus, whilst we acknowledge that our samples
were small; our results are suggestive of a potential bias
found at the lower end of the scale. A stronger study
design involving a qualitative exploration of the students’
interpretations of the discrepant items may well have
endorsed this finding.
Whilst this finding led to the refinement of the
Welsh BDI-II, it also has several wider implications for
instrument translators and developers. Firstly, it draws
Table 3 Summary of items and potential interpretations which caused bias in the student sample




0 I don’t feel I am being
punished
I don’t feel I am being punished
1 I feel I may be punished 1Rydw i’n teimlo y gallwn i gael fy nghosbi






2 I expect to be punished I expect to be punished
3 I feel I am being punished I feel I am being punished
9.Suicidal
thoughts
0 I don’t have any thoughts
of killing myself
2Dydw i ddim yn meddwl am ladd fy hun





1 I have thoughts of killing
myself but I would not
carry them out
3Rydw i wedi meddwl am ladd fy hun ond
fyddwn i byth yn gwneud (I have thought





2 I would like to kill myself I would like to kill myself
3 I would kill myself if I had
the chance
I would kill myself if I had the chance
15.Loss of
energy
0 I have as much energy as
ever
I have as much energy as ever
1 I have less energy than I
used to have
I have less energy than I used to have
2 I don’t have enough energy
to do very much
4Does gen i ddim digon o egni i wneud fawr
o ddim (I don’t have enough energy to do
much of anything)
Welsh translation reflects
greater loss of energy
Underscoring of item
in Welsh BDI-II
3 I don’t have enough energy
to do anything
I don’t have enough energy to do anything
1 ‘Gallwn’ is a derivative of the auxillary verb ‘gallu’ (may/can/be able to). 2 3The literal translation of ‘thoughts of killing myself’ is ‘meddyliau am ladd fy hun’ but
the plural form is not a natural expression in Welsh. Hence the adoption of the singular form ‘meddwl” (thought). 4’Gwneud fawr o ddim’ (lit. do much of
anything) is a natural expression in Welsh meaning’do very much’.
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tion of everyday vocabulary. Secondly, it demonstrates
the importance of ensuring that the translated version
of a measure is scaled in an equivalent way as the ori-
ginal version. Thirdly, and more importantly, this
finding confirms the value of investigating item dis-
crepancies through early exploratory psychometric eva-
luations of translated measures prior to large-scale,
psychometric testing.
Recommendations
On the basis of our findings, we propose an additional
final step (early psychometric testing) to the ISPOR
guidelines [3]. This offers a novel, cost-effective ap-
proach towards bridging the linguistic and psychometric
testing of PROMs that plugs a gap in the current litera-
ture and brings the rigour associated with clinical re-
search development to the translation and validation
platform.
Abbreviations
(AGFI): Adjusted Goodness of Fit Index; (AMOS): Analysis of Moment
Structures for Windows; (BDI-II): Beck Depression Inventory-II; (EQ-
5D): European Quality of Life-5 Dimensions; (FolATED): Folate Augmentation
of Treatment - Evaluation for Depression; (GFI): Goodness of Fit Index;
(HADS): Hospital Anxiety and Depression Scale; (ISPOR): International Society
for Pharmacoeconomics and Outcomes Research; (PROMs): Patient reportedoutcome measures; (PASW): Predictive Analytic Software; (RMR): Root Mean
Square Residual; (SF-12 v2): Short-Form 12-item Health Survey version 2.
Competing interests
The authors declare that they have no competing interests.
Acknowledgements
We are grateful to the translators, Dr Sylvia Prys, Dawi Griffiths and Gruffydd
Prys; to the FolATED team; and to the students and service users for their
valuable contribution to this study. The validation study was funded by
NISCHR; and the FolATED trial is funded by the National Institute for Health
Research Health Technology Assessment programme.
Author details
1Centre for Health-Related Research, School of Healthcare Studies, Bangor
University, Fron Heulog, Ffriddoedd Road, Bangor, Gwynedd LL57 2EF, UK.
2Institute of Medical and Social Care Research, Bangor University, Cambrian
House, Wrexham Technology Park, Wrexham LL13 7YP, UK. 3North Wales
Organisation for Randomised Trials in Health, Bangor University, Y Wern,
Normal Site, Bangor, Gwynedd LL57 2PX, UK. 4School of Medical Sciences,
Bangor University, Brigantia Building, Penrallt Road, Bangor, Gwynedd LL57
2AS, UK. 5Betsi Cadwaladr University Health Board, Ysbyty Gwynedd,
Penrhosgarnedd, Bangor, Gwynedd LL57 2PW, UK. 6Language Technology
Unit, Canolfan Bedwyr, Bangor University, Dyfrdwy, College Road, Bangor,
Gwynedd LL57 2PX, UK.
Authors’ contributions
GR conceptualised and designed the study, acquired and interpreted the
data and drafted the manuscript. SR and RT conceptualised and designed
the study, acquired and interpreted the data and revised the manuscript. RW
supervised the data analysis, interpreted the data and revised the
manuscript. EB acquired and interpreted the data and revised the
Roberts et al. Health and Quality of Life Outcomes 2012, 10:64 Page 6 of 6
http://www.hqlo.com/content/10/1/64manuscript. ST, DP and HO acquired the data and YS analysed the data. All
authors read and approved the final manuscript.
Authors’ information
GR is director of LLAIS, the Language Awareness Infrastructure Support
Service of the National Institute for Social Care and Health Research (NISCHR)
Clinical Research Centre in Wales, UK. LLAIS is committed towards
developing and validating Welsh language versions of PROMs for the
bilingual context of Wales; and establishing the evidence base for best
practice in the translation and validation of outcome measures.
Received: 8 September 2011 Accepted: 8 June 2012
Published: 8 June 2012
References
1. Streiner D, Norman G: Health Measurement Scales: a practical guide to their
development and use. 4th edition. Oxford: Oxford University Press; 2008.
2. Frost MH, Reeve BB, Liepa AM, Stauffer JW, Hays RD: What is sufficient
evidence for the reliability and validity of patient reported outcome
measures? Value Health 2007, 10(Suppl 2):S94–S105.
3. Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, Erikson
P: Principles of good practice for the translation and cultural adaptation
process for patient-reported outcomes (PRO) measures: report of the
ISPOR task force for translation and cultural adaptation. Value Health
2005, 8:94–104.
4. Acquardo C, Conway K, Hareendran A, Aaronson N: Literature review of
methods to translate health-related quality of life questionnaires for use
in multinational clinical trials. Value Health 2007, 11:509–521.
5. Beck AT, Steer RA, Brown GK: Manual for the Becks Depression Inventory II.
San Antonio TX: Psychological Corporation; 1996.
6. Bonicatto S, Dew AM, Soria JJ: Analysis of the psychometric properties of
the Spanish version of the Beck Depression Inventory in Argentina.
Psychiatry Res 1998, 79:227–285.
7. Suarez-Mendoza AA, Cardiel MH, Caballero-Uribe C, Ortega-Soto HA,
Márquez-Marin M: Measurement of depression in Mexican patients with
rheumatoid arthritis: validity of the Beck Depression Inventory. Arthr Care
Res 1997, 10:194–199.
8. Kojima M, Furukawa TA, Takahashi H, Kawai M, Nagaya T, Tokudome S:
Cross cultural validation of the Beck Depression Inventory-II in Japan.
Psychiatry Res 2002, 110:291–299.
9. EuroQol Group, EQ-5D™: The EuroQol: a new facility for the measurement
of health-related quality of life. Health Policy 1990, 6:199–208.
10. Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta
Psychiat Scand 1993, 67:361–370.
11. Ware JE, Kosinski M, Keller SK: SF-36W Physical and Mental Health Summary
Scales: A User's Manual. Boston: The Health Institute; 1994.
12. Roberts SH, Bedson E, Hughes D, Lloyd K, Menkes DB, Moat S, Pirmohamed
M, Slegg G, Thome J, Tranter R, Whitaker R, Wilkinson C, Russell I: Folate
augmentation of treatment - evaluation for depression (folated): a
protocol of a randomised controlled trial. BMC Psychiatry 2007, 7:65.
13. Montgomery SA, Asberg M: A new depression scale designed to be
sensitive to change. Br J Psychiat 1979, 135:382–389.
14. IBM: PASW Statistics 18. Chicago, IL: SPSS, Inc; 2010.
15. IBM: AMOS 18. Chicago, IL: Smallwaters Corporation; 2010.
16. Bland JM, Altman DG: Statistical methods for assessing agreement
between two methods of clinical measurement. Lancet 1986, Feb 8;
1(8476):307–310.
17. Wang YP, Andrade LH, Gorenstein C: Validation of the Beck Depression
Inventory for a Portugese-speaking Chinese community in Brazil.
Brazilian. J Med Biol Res 2005, 38:399–408.
18. Bjelland I, Dahl AA, Haug TT, Neckelmann D: The validity of the Hospital
Anxiety and Depression Scale: and updated literature review. J
Psychosom Res 2002, 52:69–77.
19. Arnarson PÖ, Ólason DP, Smári J, Sigurdsson JF: The Beck Depression
Inventory Second Edition (BDI-II): psychometric properties in Icelandic
student and patient populations. Nordic J Psychiat 2008, 62:360–365.
20. Kapci EG, Uslu R, Turkcapar H, Karaoglan A: Beck Depression Inventory II:
evaluation of the psychometric properties and cut-off points in a Turkish
adult population. Depress Anxiety 2008, 25:E104–E110.
21. McKenna SP, Doward LC: The translation and cultural adaptation of
patient-reported outcome measures. Value Health 2005, 8:89–91.22. Mapi Research Institute: Linguistic Validation of a Patient Reported Outcome
Measure. Lyon: Mapi Research Institute; 2005.
doi:10.1186/1477-7525-10-64
Cite this article as: Roberts et al.: Enhancing rigour in the validation of
patient reported outcome measures (PROMs): bridging linguistic and
psychometric testing. Health and Quality of Life Outcomes 2012 10:64.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
